Paxman AB (publ)

kr 62.50As of Sun 8 Nov 2026, 12:00 UTC
STO:PAXHealthcare
Country Sweden
PE (Fwd) •••
TSR 9Y CAGR 21.00%
Div yield —
ROE (1.30%)
Medical Devices
Beta (5Y) 0.51
PE TTM —
TSR TTM (8.36%)
Mkt cap kr 1.455B
ROIC (1.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 77
23.95%
(88.94%)
Hold 5|11|8|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
1.42
1.47
1.52
1.51
30.32%
20.95%
18.45%
8.51%
Revenuekr M
112.8
116.9
123.8
130.2
9.86%
10.00%
10.31%
19.30%
Peers (US$147.1M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.747
(0.243)
(0.236)
EBIT/Intx
0.599
0.101
0.102
Own earn%
9.44
261.17
168.33
Sh yield%
35.82
24.68
28.50
Owners
Insiders/Inst%
5.90
62.59
Short interest%
3.35
SBC / revenue%
3.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
3–12
$1 testx
—
Incr. ROIC%
2